Hospital Admin Articles

Hospital Admin

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Covidien , a leading global provider of healthcare products, announced that one of its Pharmaceutical Products subsidiaries has acquired the licensing rights to drug candidate Exalgo, Extended-Release Tablets, a formulation of an opioid analgesic from Neuromed Development Inc., a subsidiary of Neuromed Pharmaceuticals Ltd. The agreement is aimed at expanding Covidien's presence in the branded pain management market.


Today in Licensure/Accreditation...keeping you current

California licensing backlog keeping doctors from starting jobs
American Medical News , 11/10/09

The Joint Commission Introduces Perinatal Care Core Measures
Joint Commission news, 11/24/09

Models of consumer value cocreation in health care
Health Care Management Review, 11/05/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address